MeSH tree: D27.505.696.422
Medicare prescriptions for Wegovy increased sharply after the program started covering the anti-obesity medication to prevent heart problems, but just a fraction of beneficiaries likely eligible received the treatment, according ...
Jul 9, 2026
0
6
GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health benefits as well. Findings from experiments on mice, published in the Journal of Virology, suggest ...
Jul 9, 2026
0
3
Obesity rates among U.S. adults and children rose sharply in recent years, and by 2023, 40% of adults and 20% of youth met the criteria for obesity, according to new, independent research published in Circulation.
Jul 8, 2026
0
8
For decades, it's been against the law for Medicare to pay for weight-loss medication. But that changed on July 1, with the launch of a new program called Bridge. It gives some people over 65, or who have Medicare for other ...
Jul 2, 2026
0
13
According to new, independent research published in the Journal of the American Heart Association, GLP-1 receptor agonist (GLP-1 RA) medications reduce the number of deaths, amputations and hospitalizations among people with ...
Jul 1, 2026
0
5
As the use of GLP-1 medications for weight loss surges, so do calls to U.S. poison control centers, according to a new study.
Jun 25, 2026
0
6
Researchers at the University of Tartu showed that large language models can identify with high accuracy why patients stop using antidiabetic medications or statins based on doctors' electronic clinical notes. The study opens ...
Jun 25, 2026
0
2
As people age, they often develop chronic conditions, many of which need to be managed with multiple prescription medications. While medications are important for disease management, polypharmacy poses an increased risk for ...
Jun 25, 2026
0
2
A study by researchers from the University of Cambridge, the British Heart Foundation Data Science Center at Health Data Research UK and The George Institute for Global Health is the first to analyze obesity trends from 2019 ...
Jun 24, 2026
0
4
A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to a 12% reduction in body weight after 36 weeks, according to a randomized phase II clinical trial published in Nature ...
Jun 24, 2026
1
83
